037137Z
Dilation Internal Mammary Artery, Left to No Qualifier with Intraluminal Device, Drug-eluting, Four or More, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 3 Upper Arteries |
| Operation | 7 Dilation |
| Body Part | 1 Internal Mammary Artery, Left |
| Approach | 3 Percutaneous |
| Device | 7 Intraluminal Device, Drug-eluting, Four or More |
| Qualifier | Z No Qualifier |
Operation Definition
Expanding an orifice or the lumen of a tubular body part
Procedure Overview
Dilation procedures widen a narrowed or blocked segment of an upper artery, most often through balloon angioplasty with or without stent placement, to restore adequate blood flow to the brain, neck, or arm. Arteries like the carotid, subclavian, and brachial commonly develop narrowing from atherosclerotic plaque, and dilation is one of the least invasive ways to correct it.
A catheter carrying a balloon, and often a stent, is threaded to the narrowed site under imaging guidance; the balloon is inflated to compress the plaque against the vessel wall, and a stent may be left in place to hold the artery open afterward. This is typically attempted before a bypass is considered, since it avoids open surgery and graft material.
Patients undergo this procedure to reduce stroke risk, relieve arm claudication or ischemia, and avoid a more invasive vascular reconstruction, with the artery's own wall preserved rather than replaced or rerouted.
Anatomy & Axis Detail
Internal Mammary Artery, Left
The left internal mammary artery is the vessel most frequently used as a coronary bypass conduit because of its durability, so dilation of this artery usually addresses a stenosis within or at the anastomosis of an existing mammary-to-coronary graft rather than a primary arterial disease process. A tight lesion here can silently compromise flow to the left anterior descending territory it was constructed to supply, making balloon dilation, with or without stent placement, an important salvage option before graft failure occurs. The procedure is done through selective catheter engagement of the artery's ostium under fluoroscopic guidance. Coders should confirm from the report whether the treated segment is the native left mammary artery or the coronary vessel beyond the graft insertion point.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Intraluminal Device, Drug-eluting, Four or More
Four or More Drug-eluting Intraluminal Devices captures procedures in which four or more such devices, commonly coronary stents, are implanted in the same body part in one session. It represents the upper end of the drug-eluting device-count scale, distinguished from the Two and Three counts only by quantity, and from the non-drug-eluting four-or-more value by the presence of a pharmacologic coating.
Coding & Documentation
Coding a Dilation requires documentation of the artery treated and whether a stent was deployed, since the device value changes between no device, a drug-eluting stent, a non-drug-eluting stent, or an intraluminal device without drug coating. The approach, percutaneous versus open, also affects code selection. A frequent error is failing to capture a stent placed during the same session as a separate consideration, when in fact PCS bundles the stent into the Dilation code's device character rather than coding it separately; another is confusing pre-dilation performed to facilitate stent placement, which is not coded independently, with a therapeutic dilation of a different vessel.